Non-hodgkin lymphoma : nature.com subject feeds
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
Management of prolonged cytopenia following CAR T-cell therapy
CAR Treg cells: prime suspects in therapeutic resistance
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition
R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides
Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients – targeting the target antigen
Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission
Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial
A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
A phase two study of high dose blinatumomab in Richter’s syndrome
A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma
Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia
T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL
Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study
CC chemokine receptor 2 (CCR2) expression promotes diffuse large B-Cell lymphoma survival and invasion
APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age
Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
SHINE a light: frontline ibrutinib for MCL
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Feed Fetched by RSS Dog.